GSK mRNA Flu Vaccine Candidate Delivers Favorable Topline Phase 2 Findings, Ready for Phase 3

Retrieved on: 2024-09-12 17:15:41

Tags for this article:

Click the tags to see associated articles and topics

GSK mRNA Flu Vaccine Candidate Delivers Favorable Topline Phase 2 Findings, Ready for Phase 3. View article details on hiswai:

Excerpt

Positive topline phase 2 data reported by GSK today for its seasonal influenza mRNA vaccine support progression of the formulation to phase 3 ...

Article found on: www.patientcareonline.com